BrainChild Bio
Phase 1BrainChild Bio is a kids-first, clinical-stage biotechnology company harnessing the power of CAR-T cell technology for tumors in the central nervous system (CNS), prioritizing pediatrics with plans to expand our technology platform to adult indications.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $3.5M
About
BrainChild Bio is a kids-first, clinical-stage biotechnology company harnessing the power of CAR-T cell technology for tumors in the central nervous system (CNS), prioritizing pediatrics with plans to expand our technology platform to adult indications.
NeuroscienceRare Disease
Funding History
2Total raised:$3.5M
Grant$500KAug 15, 2021
Seed$3MMar 15, 2020